H.R. 2484

119th Congress

Reported

Seniors’ Access to Critical Medications Act of 2025

Sponsored byRepublican:Rep. Harshbarger, Diana [R-TN-1]TN· Introduced 31 mars 2025

26

Cosponsors

6

Actions

0

Amendments

2

Committees

Since introduced

Introduced
Committee
Passed Chamber
Passed Both
Enacted
Step 1 of 0
Latest action

Ordered to be Reported by the Yeas and Nays: 38 - 7.

29 avril 2025·1 year ago

Summary

Introduced in House · Updated 14 avril 2026

Seniors’ Access to Critical Medications Act of 2025

This bill temporarily expands flexibilities under the Stark law (i.e., the Physician Self-Referral Law) for certain physicians who dispense covered outpatient drugs under the Medicare prescription drug benefit at the physician's office location (e.g., through an integrated pharmacy). The Stark law generally prohibits physicians from referring patients to receive services that are payable under Medicare or Medicaid from entities in which the physician or an immediate family member has a financial relationship. 

Specifically, the bill allows, from 2026-2030, physicians to dispense such drugs from the physician's office, including through in-person pickup by a caregiver or via mail, if (1) the physician prescribed the drug, (2) the beneficiary has an ongoing relationship with the physician, (3) the beneficiary had at least one face-to-face visit with the physician in the prior year, and (4) the physician bills for the drug. These requirements also apply to physicians within the same group practice.

The Government Accountability Office must report on pharmacies or pharmacy networks that dispense significantly more covered drugs under the Medicare prescription drug benefit after the bill's enactment, the extent to which such pharmacies and networks are owned by physicians or integrated into physician practices, and the common characteristics of these types of arrangements.

Timeline

6 actions

  1. Committee Consideration and Mark-up Session Held

    29 avril 2025 · Committee

  2. Ordered to be Reported by the Yeas and Nays: 38 - 7.

    29 avril 2025 · Committee

  3. Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

    31 mars 2025 · IntroReferral

  4. Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

    31 mars 2025 · IntroReferral

  5. Introduced in House

    31 mars 2025 · IntroReferral

  6. Introduced in House

    31 mars 2025 · IntroReferral

Sponsorship

26 cosponsors

Cosponsors

  • Democrat1038%
  • Republican1662%

Classification

Policy area

Health

Legislative subjects

Congressional oversightGovernment studies and investigationsHealth personnelMedicarePrescription drugs

Committees

2

  • Energy and Commerce Committee

    House · Standing

    • Referred To31 Mar 2025
    • Markup By29 Apr 2025
  • Ways and Means Committee

    House · Standing

    • Referred To31 Mar 2025

Cosponsor momentum

Cumulative over time

Cosponsors grew from 5 on 31 mars 2025 to 26 on 8 juin 2026.

Pelosi Tracker
© 2026 - Tous droits réservés. Propulsé par Vantara Labs
Ce site web est une plateforme indépendante et tierce. Il n'est pas affilié à, approuvé par ou associé de quelque manière que ce soit à Nancy Pelosi, son bureau ou ses représentants. Toute utilisation de son nom est uniquement à des fins de discussion d'informations publiques disponibles.Les informations fournies sur ce site web sont uniquement à des fins informatives et éducatives et ne sont pas destinées à servir de conseils financiers ou d'investissement, ni ne doivent être interprétées comme tels. Les données présentées ici proviennent de déclarations et dossiers publics. Bien que nous nous efforcions d'assurer l'exactitude, l'actualité et l'exhaustivité, nous ne garantissons pas que toutes les informations sont exemptes d'erreurs ou à jour.Le support est disponible en anglais. Certaines traductions sont automatiques.